Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RS-2102 by Reistone Biopharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
RS-2102 is under clinical development by Reistone Biopharma and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According to...